SueWallSt Podcast Update: Levi & Korsinsky Details RICK Class Action Claims

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding RCI Hospitality Holdings, Inc. (NASDAQ:RICK) class action securities lawsuit A Class Action lawsuit was filed on behalf of RCI Hospitality Holdings, Inc. investors who lost money as a result of alleged securities fraud between December 15, […]

Industrial AI Applied: IFS Showcases Real-World Impact of AI Through Industry-Specific Scenarios

IFS expands ecosystem of Frontier AI, Robotics, Grid Tech and Business Advisory by forging new partnerships with leading AI tech companiesAnthropic, 1X Technologies, Siemens and collaboration with Boston Dynamics Industrial X Unleashed, New York, NY – November 13, 2025 – IFS, the leading provider of Industrial AI software, is today showcasing the next wave of

Lost Money on Sprouts Farmers Market, Inc. (SFM)? You May Have Been Affected by Fraud – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sprouts Farmers Market, Inc. ("Sprouts Farmers Market, Inc.") (NASDAQ:SFM) concerning possible violations of federal securities laws. On October 29, 2025, Sprouts unveiled its third quarter fiscal 2025 results, which highlighted a worrying

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease

(NASDAQ:CGTX), PURCHASE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the company has reached target enrollment of 540 participants in the randomized, placebo-controlled Phase 2 'START' Study. A number of additional patients are in the

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer's Disease Study conducted in collaboration with the Alzheimer's Clinical Trials Consortium GlobeNewswire November 13, 2025 PURCHASE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative

Charity walkathon WeWalk returns to unite Dubai residents in support of children with diabetes

— WeWalk, organised by TECOM Group and held in partnership with Dubai Charity Association, returns in its sixth year to support the treatment of children with diabetes — Dubai's residents invited to walk, jog, run, or cycle during an action-packed morning with live performances, fitness sessions, and prize giveaways Charity walkathon WeWalk is set to

Levi & Korsinsky Urges CarMax, Inc. (KMX) Shareholders to Act Before Lead Plaintiff Deadline January 2, 2026

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=177115&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Lennox International Inc. (LII) Shareholders May Have Been Affected by Fraud – Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lennox International Inc. ("Lennox International Inc.") (NYSE:LII) concerning possible violations of federal securities laws. On October 22, 2025, Lennox published mixed third quarter 2025 financial results. Particularly, the Company disclosed that it

LRN Shareholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Against Stride, Inc.

(NYSE:LRN), SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025. Stride is a technology company that provides an education platform to deliver online

Sunrise Realty Trust, Inc. Announces Financial Results for the Third Quarter 2025

(NASDAQ:SUNS), WEST PALM BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS” or the “Company”), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced its results for the quarter ended September 30, 2025. SUNS reported generally accepted accounting principles (“GAAP”) net income of $4.05 million

Scroll to Top